STAAR Surgical Taps Align Technology Exec as CTO to Drive Platform Expansion
Event summary
- STAAR Surgical appointed Ben Park, Ph.D., as Chief Technology Officer, effective September 2026.
- Park joins from Align Technology, where he led emerging technology initiatives since 2018.
- STAAR aims to transition from a single-product focus to a multi-product platform strategy.
- Park's background includes co-founding Fluid Medical and leading tech development at Volcano Corporation.
- STAAR will showcase its innovation roadmap at the 44th Congress of the ESCRS in London.
The big picture
STAAR Surgical is doubling down on innovation as it seeks to transition from a single-product leader to a multi-product platform. The appointment of Ben Park, with his track record in building and commercializing medical device platforms, signals a strategic shift to capitalize on the growing global myopia crisis. With over 4 million ICLs sold in 85 countries, STAAR is positioning itself to expand its proprietary Collamer technology into new clinical areas.
What we're watching
- Platform Diversification
- How STAAR will leverage Park's experience to expand beyond its core ICL product line.
- R&D Execution
- Whether STAAR can accelerate its next-generation product pipeline under Park's leadership.
- Market Expansion
- The pace at which STAAR can address unmet clinical needs in myopia and beyond.